
Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15
Published: Nov. 22, 2024
The A/H1N1pdm09 influenza virus, which caused the 2009 pandemic, has since become a recurring strain in seasonal outbreaks. Given ongoing threat of influenza, protein subunit vaccines have garnered significant attention for their safety and effectiveness. This review seeks to highlight latest developments that specifically target virus. It will also examine structure replication cycle A viruses compare different types vaccines. Additionally, address key aspects H1N1 vaccine development, such as antigen selection, expression systems, use adjuvants. role animal models evaluating these be discussed. Despite challenges like antigenic variability complexities production distribution, remain promising option future prevention efforts.
Language: Английский